These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 8019060)
21. Characterization of plasmin-induced platelet aggregation. Watabe A; Ohta M; Matsuyama N; Mizuno K; el Borai N; Tanimoto T; Kawanishi T; Hayakawa T Res Commun Mol Pathol Pharmacol; 1997 Jun; 96(3):341-52. PubMed ID: 9261893 [TBL] [Abstract][Full Text] [Related]
22. Cytoskeletal changes in platelets induced by thrombin and phorbol myristate acetate (PMA). Chen R; Liang N Cell Biol Int; 1998; 22(6):429-35. PubMed ID: 10328851 [TBL] [Abstract][Full Text] [Related]
23. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity. Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972 [TBL] [Abstract][Full Text] [Related]
24. Interaction of echicetin with a high affinity thrombin binding site on platelet glycoprotein GPIb. Peng M; Emig FA; Mao A; Lu W; Kirby EP; Niewiarowski S; Kowalska MA Thromb Haemost; 1995 Sep; 74(3):954-7. PubMed ID: 8571328 [TBL] [Abstract][Full Text] [Related]
25. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase. Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591 [TBL] [Abstract][Full Text] [Related]
26. High-molecular-mass and low-molecular-mass kininogens block plasmin-induced platelet aggregation by forming a complex with kringle 5 of plasminogen/plasmin. Selim TE; Ghoneim HR; Uknis AB; Colman RW; DeLa Cadena RA Eur J Biochem; 1997 Dec; 250(2):532-8. PubMed ID: 9428707 [TBL] [Abstract][Full Text] [Related]
27. Identification and characterization of a collagen-induced platelet aggregation inhibitor, triplatin, from salivary glands of the assassin bug, Triatoma infestans. Morita A; Isawa H; Orito Y; Iwanaga S; Chinzei Y; Yuda M FEBS J; 2006 Jul; 273(13):2955-62. PubMed ID: 16759235 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and pharmacological evaluation of 2,3-dialkylindoles, "in vitro" inhibitors of thrombin-induced platelet aggregation. Arcari M; Aveta R; Brandt A; Cecchetelli L; Corsi GB; Solinas F Farmaco; 1992 Apr; 47(4):405-25. PubMed ID: 1388590 [TBL] [Abstract][Full Text] [Related]
29. Aggregation of washed platelets by plasminogen and plasminogen activators is mediated by plasmin and is inhibited by a synthetic peptide disulfide. Puri RN; Hu CJ; Matsueda R; Umeyama H; Colman RW Thromb Res; 1992 Mar; 65(4-5):533-47. PubMed ID: 1535463 [TBL] [Abstract][Full Text] [Related]
30. A critical role for thrombin in platelet aggregation under high shear stress. Sakurai Y; Shima M; Giddings J; Takeyama M; Kasuda S; Nogami K; Nishiya K; Yoshioka A Thromb Res; 2004; 113(5):311-8. PubMed ID: 15183043 [TBL] [Abstract][Full Text] [Related]
31. A novel method for chemical modification of functional groups other than a carboxyl group in proteins by N-ethyl-5-phenylisooxazolium-3'-sulfonate (Woodward's reagent-K): inhibition of ADP-induced platelet responses involves covalent modification of aggregin, an ADP receptor. Puri RN; Colman RW Anal Biochem; 1996 Sep; 240(2):251-61. PubMed ID: 8811919 [TBL] [Abstract][Full Text] [Related]
32. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets. Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903 [TBL] [Abstract][Full Text] [Related]
34. Platelet lipoxygenase inhibitors attenuate thrombin- and thromboxane mimetic-induced intracellular calcium mobilization and platelet aggregation. Nyby MD; Sasaki M; Ideguchi Y; Wynne HE; Hori MT; Berger ME; Golub MS; Brickman AS; Tuck ML J Pharmacol Exp Ther; 1996 Aug; 278(2):503-9. PubMed ID: 8768697 [TBL] [Abstract][Full Text] [Related]
35. Effect of aprotinin and recombinant variants on platelet protease-activated receptor 1 activation. Day JR; Haskard DO; Taylor KM; Landis RC Ann Thorac Surg; 2006 Feb; 81(2):619-24. PubMed ID: 16427862 [TBL] [Abstract][Full Text] [Related]
36. Effects of P2Y(1) and P2Y(12) receptor antagonists on platelet aggregation induced by different agonists in human whole blood. Storey RF; Newby LJ; Heptinstall S Platelets; 2001 Nov; 12(7):443-7. PubMed ID: 11674863 [TBL] [Abstract][Full Text] [Related]
37. Kinetics of inhibition of platelet calpain II by human kininogens. Bradford HN; Schmaier AH; Colman RW Biochem J; 1990 Aug; 270(1):83-90. PubMed ID: 2396995 [TBL] [Abstract][Full Text] [Related]
38. Cleavage of a 100 kDa membrane protein (aggregin) during thrombin-induced platelet aggregation is mediated by the high affinity thrombin receptors. Puri RN; Zhou FX; Colman RF; Colman RW Biochem Biophys Res Commun; 1989 Aug; 162(3):1017-24. PubMed ID: 2475104 [TBL] [Abstract][Full Text] [Related]